Viz.ai has announced the CE mark of its direct-to-intervention system, ContaCT, a novel approach to stroke care that automatically analyses brain CTs and notifies a specialist that a suspected large vessel occlusion has been identified.
Viz.ai CEO and co-founder Chris Mansi said, “Today’s stroke care is indirect, with lengthy time to treatment. Direct-to-intervention care provides the right information to the right doctor at the right time, greatly expediting the assessment and treatment process. Our direct-to-intervention system represents a paradigm shift in stroke care, one which promises to speed workflow and increase access. When every minute matters, there is a compelling advantage in being able to identify and transfer patients faster. This approach could potentially save countless lives, greatly reduce disability and decrease the cost burden to healthcare systems.”
Viz.ai’s direct-to-intervention system utilises deep learning algorithms to automatically identify large vessel occlusions that are responsible for the most devastating of strokes, and involves a stroke specialist in the care of that patient earlier than possible through conventional means.
Viz.ai’s approach recognises the importance of timely intervention by stroke specialists as supported by the American Stroke Association’s updated guidelines. From the latest STRATIS registry, current workflows can result in a door-to-treatment time of several hours resulting in poor patient outcomes. Viz.ai’s software has demonstrated its potential in a clinical trial, where it was able to correctly notify stroke specialists of a suspected large vessel occlusion in a matter of minutes thus potentially reducing the time to intervention.
